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EDITORIAL COMMENT
Concurrent Balloon Dilation of
Stenosed Aortopulmonary
Gore-Tex Shunts and Branch
Pulmonary Arteries*
P. Syamasundar Rao, MD, FACC
St. Louis, Missouri
Cyanotic congenital heart defects (CCHD) with severe
pulmonary stenosis or atresia exhibit hypoxemia and cyano-
sis secondary to pulmonary oligemia and right-to-left shunt.
Even though a substantial proportion of these patients can
be surgically corrected at presentation, such correction is not
feasible in some patients either because of the age and size
of the patient at presentation or because of anatomic
complexity of the CCHD. In such patients, pulmonary
blood flow may be augmented by creation of a systemic-to-
pulmonary artery anastomosis; such palliative procedures
improve hypoxemia and allow the infant to grow to an age
and size when “corrective” surgery could be performed.
Following the description by Blalock and Taussig (1) in
1945 of anastomosis of subclavian artery to the ipsilateral
pulmonary artery, a number of other systemic-to-pulmonary
artery shunt procedures, reviewed elsewhere (2), have been
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described. However, the classic Blalock-Taussig (BT) shunt
(1) or a modified version with an interposition Gore-Text
tube graft between the subclavian artery and the ipsilateral
pulmonary artery, described by deLeval et al. (3), stood the
test of time and remained the palliative procedures of choice
for augmenting pulmonary blood flow. Although these
shunts have generally been useful, stenosis of the shunt can
develop, causing recurrence of hypoxemia and cyanosis. If
shunt stenosis develops before the child reaches suitable age
and size for safe surgical correction, an additional palliative
shunt may have to be performed. Balloon angioplasty of the
BT shunt is useful in such situations.
Balloon angioplasty of narrowed BT shunt was first
reported by Fischer et al. (4); they balloon-dilated a ste-
nosed classic BT shunt in a four-year-old, with resultant
improvement of systemic arterial oxygen saturation from
68% to 80%. Subsequently, a number of other investigators,
reviewed elsewhere (5,6) and in the report by Wang et al.
(7), have reported their experience with this procedure. The
majority of reports describe dilation of classic BT shunt and
some involve modified BT shunts.
In this issue of the Journal, Wang et al. (7) present the
results of balloon angioplasty of stenosed-modified BT or
central aortopulmonary shunts in 46 patients. The proce-
dure was deemed effective (defined as an increase in shunt
diameter $20% or an increase in systemic arterial oxygen
saturation $3%) in 42 (91%) of 46 patients. Obstructive
lesions were present in the subclavian artery, tube graft,
and/or at the anastomotic sites. Balloon angioplasty of
stenosed branch pulmonary arteries with the balloon cath-
eter introduced through the BT shunt was performed
concurrently. The latter procedure was effective (defined as
increase in stenotic diameter .50%) in 14 (56%) of 25
vessels in whom balloon angioplasty was feasible. The
systemic arterial oxygen saturation increased, though mod-
estly, from the mid-70s to low 80s. No major complications
related to the procedure were observed. At a mean
follow-up of 12 months in 29 patients, recurrence of
obstruction was seen in three (10%) patients. In the remain-
ing 26 (90%) patients, the size of the stenotic segment did
not significantly change. Improvement of McGoon ratio
occurred. The next stage of surgery was undertaken in 26
patients. Thus, a substantial clinical benefit was accrued in
a good number of these patients. Based on these data, the
investigators concluded that balloon angioplasty is an effec-
tive alternative to a second shunt and that concurrent
dilation of branch pulmonary artery stenosis is feasible.
Whereas both the feasibility and the efficacy of balloon
angioplasty of classic BT shuts (i.e., without Gore-Tex
grafts) have been well documented, balloon dilation of the
stenoses associated with Gore-Tex grafts has not been well
studied, save for a few case reports (8–11). One group of
workers (12) advocated the use of classic BT shunts in
preference to modified BT shunts in the palliation of
CCHD based on: 1) success they observed in dilating
stenosed classic BT shunts, and 2) theoretical assumption
that a modified BT shunt is not suited for balloon angio-
plasty because of the “sharp” angle that the graft forms with
the subclavian artery. This myth is dispelled by the success
of modified BT shunt angioplasty reported by Wang et al.
(7). In addition to presenting a large series of modified BT
shunt dilations, the investigators also demonstrate feasibility
and effectiveness of dilating branch pulmonary arteries via
the BT shunts. However, the definition of effectiveness used
by the investigators is somewhat lax—for example, an
increase in O2 saturation of 3%. Similarly, requirement for
another shunt in eight (17%) patients during the same
admission should not be considered “effective” dilation.
Only 37 (80%) of 46 patients were discharged home without
additional procedures.
Furthermore, the investigators (7) did not make an
attempt to identify characteristics of stenotic lesions that are
likely to respond favorably to balloon angioplasty. Despite
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these limitations, the authors’ data, along with the previ-
ously published reports, are useful to the pediatric cardiol-
ogist in assessing the feasibility, safety and effectiveness of
balloon angioplasty of modified BT shunts and of the
branch pulmonary artery accessed through the BT shunts.
Furthermore, the report affords an opportunity to discuss
several issues germane to balloon angioplasty of BT shunts
and branch pulmonary arteries.
Indications. The indication for performing balloon angio-
plasty used by Wang et al. (7) is that the child is not a
suitable candidate for definitive repair, but at the same time
requires palliation of pulmonary oligemia, very similar to
what we have used for balloon angioplasty of BT shunts
(5,6,13) and balloon pulmonary valvuloplasty (5,6,14,15) in
the late 1980s. Recently, however, total corrective opera-
tions are being performed in increasing numbers of patients
during the neonatal period and during early infancy at
increasing numbers of institutions. Thus, the need for
performing BT shunts becomes less frequent. Conse-
quently, the necessity for performing balloon angioplasty is
even less. Furthermore, patients with univentricular physi-
ology (for example, tricuspid atresia, double-inlet left ven-
tricle and hypoplastic left heart syndrome) can undergo the
bidirectional Glenn procedure as early as three months of
age followed later by total cavopulmonary connection.
Following the initial experience with the procedure (13), we
used to perform balloon angioplasty frequently, whereas
during the last five years we performed this procedure only
occasionally, thus attesting to the change in the need for
performing the procedure. Given these considerations, it is
prudent to evaluate carefully the indications for the proce-
dure and use it only if reparative procedures for correctable
lesions or the bidirectional Glenn procedure for univen-
tricular physiology patients could not be undertaken safely.
A substantial proportion of these CCHD patients have
associated pulmonary atresia or the pulmonary artery cannot
be catheterized directly either because of severe stenosis or
because of abnormal or atypical position. Demonstration of
pulmonary arterial anatomy and measurement of pulmonary
artery pressure are of obvious value in the overall manage-
ment of the patient. This is an additional indication for
balloon angioplasty of the BT shunt, to facilitate access into
the pulmonary artery.
Technique. The technique has been described in the past.
We have used a multipurpose or a right coronary artery
catheter (Cordis, Miami, Florida) to gain access into the BT
shunt. Others use Cook Cobra or Headhunter catheters
(Cook, Bloomington, Indiana). These catheters, with the
help of soft-tipped guide wires, can be advanced into the
pulmonary artery via the BT shunt. If this is not possible, a
balloon-on-a-wire (13) may be used to dilate the shunt
initially, followed by a more appropriate size balloon for
angioplasty. The size of the balloon employed to dilate the
shunt should be two or more times the narrowed segment
diameter or the size of the Gore-Tex graft utilized in the
BT shunt. The balloon diameter need not exceed the size of
the subclavian artery feeding the shunt. With the availability
of low-profile catheters that track well such as Tyshak-II
balloons and more recently Tyshak Mini balloons (NuMed,
Nicholville, New York), it is likely that positioning the
balloon catheters across the stenotic lesion is easier than in
the past.
There is a concern with the potential for development of
acute hypoxemia during balloon angioplasty of BT shunt
because of complete occlusion of it during angioplasty. We
have not observed such a problem in our own case material
(6,13). Wang et al. (7) observed a transient drop in O2
saturation, which promptly improved by O2 administration
by mask or hood and withdrawal of the balloon catheter.
Lack of a significant problem may be related to alternative
pulmonary blood flow through bronchial collateral vessels,
contralateral BT shunt or anterograde flow through the
stenotic pulmonary valve. Our observation is that the more
severe the degree of BT shunt stenosis, the less is the
probability for developing acute hypoxemia during BT
shunt angioplasty.
Use of heparin during the procedure is generally recom-
mended. We continue the heparin overnight until the next
morning to prevent thrombosis (16) of freshly catheterized
BT shunt.
Balloon angioplasty of pulmonary artery. Balloon dila-
tion was attempted by Wang et al. (7) in 28 branch
pulmonary arteries. The procedure was accomplished in 25
(89%) arteries, a remarkable success. In the remaining three
patients either a guide wire (n 5 2) or a balloon angioplasty
catheter (n 5 1) could not be advanced distal to the
obstruction.
Effective dilation was accomplished in 14 (56%) of the 25
vessels dilated, not too different from that (58%) reported
with conventional anterograde technique (17). Perhaps the
use of stents to expand stenotic pulmonary artery segments
may be an answer to achieve greater success. Unfortunately,
the currently used Palmaz stents (18), because of the
requirement of large delivery sheath and longitudinal rigid-
ity, would not be suitable for implantation through the BT
shunts. It is possible that the newer stents, such as bridge
stents (19) or IntraStent which can traverse a tortuous
course, may become suitable for implantation. Favorable
experience with such stents is necessary prior to general use.
Summary and conclusions. The interesting study by
Wang et al. (7) is the largest series reporting balloon
angioplasty of modified BT shunt and demonstrates feasi-
bility, safety and effectiveness of balloon angioplasty of
stenosed-modified BT shunts. It also illustrates feasibility of
concurrent dilation of branch pulmonary artery through the
BT shunts. With the recent trend toward early reparative
and staged surgery, the need for BT shunts and, conse-
quently, the need for balloon angioplasty of narrowed BT
shunts become less. Whereas balloon angioplasty of branch
pulmonary artery can be performed, the success rate con-
tinues to be low. The feasibility of implanting flexible stents
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in the branch pulmonary artery through the BT shunts
should be explored in the future.
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